Proteomics

Dataset Information

0

Characterisation of VDAC2 ligands

ABSTRACT: This study aimed to characterise the protein that a novel compound binds to, thus promoting its ability to inhibit BAK apoptotic activity.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Early Embryonic Cell

SUBMITTER: Laura Dagley  

LAB HEAD: Guillaume Lessene

PROVIDER: PXD011150 | Pride | 2019-10-11

REPOSITORIES: pride

Json Xml

Dataset's files

Source:
Action DRS
P3216_Control_DIGI.raw Raw
P3216_Control_TX100.raw Raw
P3216_WEHI_DIGI.raw Raw
P3216_WEHI_TX100.raw Raw
txt.zip Other
Items per page:
1 - 5 of 5
altmetric image

Publications

A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis.

van Delft Mark F MF   Chappaz Stephane S   Khakham Yelena Y   Bui Chinh T CT   Debrincat Marlyse A MA   Lowes Kym N KN   Brouwer Jason M JM   Grohmann Christoph C   Sharp Phillip P PP   Dagley Laura F LF   Li Lucy L   McArthur Kate K   Luo Meng-Xiao MX   Chin Hui San HS   Fairlie W Douglas WD   Lee Erinna F EF   Segal David D   Duflocq Stephane S   Lessene Romina R   Bernard Sabrina S   Peilleron Laure L   Nguyen Thao T   Miles Caroline C   Wan Soo San SS   Lane Rachael M RM   Wardak Ahmad A   Lackovic Kurt K   Colman Peter M PM   Sandow Jarrod J JJ   Webb Andrew I AI   Czabotar Peter E PE   Dewson Grant G   Watson Keith G KG   Huang David C S DCS   Lessene Guillaume G   Kile Benjamin T BT  

Nature chemical biology 20191007 11

Activating the intrinsic apoptosis pathway with small molecules is now a clinically validated approach to cancer therapy. In contrast, blocking apoptosis to prevent the death of healthy cells in disease settings has not been achieved. Caspases have been favored, but they act too late in apoptosis to provide long-term protection. The critical step in committing a cell to death is activation of BAK or BAX, pro-death BCL-2 proteins mediating mitochondrial damage. Apoptosis cannot proceed in their a  ...[more]

Similar Datasets

Proteomics VDAC2 promotes BAX apoptotic activity
2018-10-29 | PXD011195 | Pride
Proteomics VDAC2 ligands selectively and potently block BAK-mediated apoptosis to allow long-term clonogenic cell survival
2019-10-11 | PXD013129 | Pride
Clinical Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
| 2746203 | ecrin-mdr-crc
Proteomics Characterisation of pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling
2016-06-09 | PXD003198 | Pride
Proteomics Label free mass spectrometry-based quantification of linker histone H1 variants in clinical samples
2021-03-16 | PXD020537 | Pride
Transcriptomics Pro-survival A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation
2023-10-17 | GSE214525 | GEO
Transcriptomics Transcriptome-wide identification of Hfq-associated RNAs in Brucella suis by deep sequencing
2015-11-25 | E-GEOD-73621 | biostudies-arrayexpress
Transcriptomics Wild type mouse embryonic fibroblasts (MEF) vs Bax/BAK double knock out MEF treated with and without Nocodazole
2023-06-12 | E-MTAB-10997 | biostudies-arrayexpress
Genomics Cardiomyocyte ST-wave depression indel characterisation (ATAC-seq)
2023-12-11 | GSE163169 | GEO
Proteomics Control and Ikbkap-knockout MEFs LC-MSMS
2022-02-17 | PXD024628 | Pride